RxSight, Inc.
RXST· Nasdaq
Released Mar 6, 2023, after the close
10-K filed Mar 6, 2023, 65 days after period end · 0000950170-23-006237
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|
| Revenue | $16.09M | $8.43M | — |
| Net Income | -$15.61M | -$15.73M | $26.30M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
RxSight, Inc. · CIK 1111485 · Engraved from SEC EDGAR